Hayek Kallen Investment Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 845 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.

Quarter-by-quarter ownership
Hayek Kallen Investment Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$4,168
+0.7%
40,921
-0.2%
1.87%
+6.0%
Q2 2023$4,138
+14.8%
41,007
+4.6%
1.76%
+8.0%
Q1 2023$3,605
-1.5%
39,188
-2.9%
1.63%
-3.3%
Q4 2022$3,660
-99.9%
40,345
-1.5%
1.69%
+15.5%
Q3 2022$3,112,000
-10.3%
40,945
-0.2%
1.46%
-3.3%
Q2 2022$3,470,000
-5.7%
41,045
-2.1%
1.51%
+10.9%
Q1 2022$3,681,000
-1.7%
41,945
-2.0%
1.36%
+2.1%
Q4 2021$3,745,000
+6.7%
42,820
-0.3%
1.34%
-16.6%
Q3 2021$3,511,000
-11.2%
42,935
-0.9%
1.60%
-3.6%
Q2 2021$3,953,000
+7.0%
43,323
+0.3%
1.66%
-0.2%
Q1 2021$3,693,000
-9.4%
43,199
+0.1%
1.66%
-15.6%
Q4 2020$4,077,000
+8.5%
43,173
-0.1%
1.97%
-6.1%
Q3 2020$3,757,000
-0.9%
43,201
-0.5%
2.10%
-2.2%
Q2 2020$3,792,000
+5.0%
43,421
-0.9%
2.15%
-11.4%
Q1 2020$3,612,000
-14.6%
43,809
-2.0%
2.42%
-0.8%
Q4 2019$4,231,000
+8.6%
44,688
-0.4%
2.44%
+0.3%
Q3 2019$3,897,000
-6.1%
44,848
-1.3%
2.43%
-7.5%
Q2 2019$4,149,000
-5.8%
45,440
-0.8%
2.63%
-7.9%
Q1 2019$4,405,000
+8.8%
45,815
-2.9%
2.86%
-1.6%
Q4 2018$4,050,000
-49.7%
47,196
-51.1%
2.90%
+8.3%
Q3 2018$8,051,000
+122.9%
96,445
+101.7%
2.68%
+7.4%
Q2 2018$3,612,000
-8.1%
47,811
-1.7%
2.50%
-8.5%
Q1 2018$3,932,000
-7.0%
48,634
-3.4%
2.73%
-1.7%
Q4 2017$4,228,000
-3.2%
50,364
-1.0%
2.77%
-7.3%
Q3 2017$4,369,000
+2.2%
50,889
-0.7%
2.99%
+3.6%
Q2 2017$4,276,000
+11.2%
51,234
-1.0%
2.89%
+8.4%
Q1 2017$3,844,000
+3.0%
51,752
+1.0%
2.66%
-2.0%
Q4 2016$3,731,000
-7.2%
51,217
+0.6%
2.72%
-5.2%
Q3 2016$4,019,000
-2.5%
50,902
+1.9%
2.87%
-3.0%
Q2 2016$4,120,000
+15.5%
49,937
+1.4%
2.96%
+11.9%
Q1 2016$3,568,000
-15.6%
49,257
+0.3%
2.64%
-18.3%
Q4 2015$4,227,000
-8.5%
49,132
-2.2%
3.24%
-10.0%
Q3 2015$4,619,000
-11.0%
50,247
-4.8%
3.59%
-7.3%
Q2 2015$5,190,000
-0.8%
52,772
-0.6%
3.88%
+0.5%
Q1 2015$5,234,000
+3.4%
53,080
-2.8%
3.86%
+3.2%
Q4 2014$5,062,000
-3.9%
54,625
-2.4%
3.74%
-6.7%
Q3 2014$5,268,000
-1.4%
55,964
-5.1%
4.01%
-0.7%
Q2 2014$5,341,000
+4.1%
58,997
-2.3%
4.04%
-1.4%
Q1 2014$5,133,000
+3.1%
60,377
-2.5%
4.10%
+5.7%
Q4 2013$4,980,000
+2.4%
61,952
-2.3%
3.88%
-3.5%
Q3 2013$4,864,000
+3.1%
63,412
-5.0%
4.02%
+0.7%
Q2 2013$4,720,00066,7473.99%
Other shareholders
NOVARTIS A G shareholders Q2 2014
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders